COHBAR INC has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are ONCLAVE THERAPEUTICS LTD, DASSEUX JEAN-LOUIS and FIBROGEN INK.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Taiwan | 2 | |
#9 | United States | 2 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Magnan Remi | 18 |
#2 | Grindstaff Kent K | 18 |
#3 | Cundy Kenneth | 16 |
#4 | Cundy Kenneth C | 10 |
#5 | Yao Yongjin | 9 |
#6 | Yan Liang Zeng | 9 |
#7 | Luo Wendy | 9 |
#8 | Liang Zeng Yan | 1 |
#9 | Nestor John J | 1 |
#10 | Remi Magnan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021030794A1 | Therapeutic peptides | |
WO2021030799A1 | Therapeutic peptides | |
WO2021030792A1 | Therapeutic peptides | |
WO2021030752A1 | Therapeutic peptides | |
WO2021030749A1 | Therapeutic peptides | |
WO2021030687A1 | Therapeutic peptides | |
WO2021030469A1 | Therapeutic mitochondrial peptides | |
WO2020160003A1 | Therapeutic peptides | |
CN112040958A | Peptide-containing formulations | |
US2020181197A1 | Therapeutic peptides | |
WO2013074871A2 | Humanin analogs |